Agenus (AGEN) Total Debt (2010 - 2026)
Agenus' (AGEN) quarterly Total Debt came in at $30.2 million in Q1 2026, down 10.08% year-on-year from $33.6 million in Q1 2025, and down 32.39% quarter-over-quarter from $44.7 million in Q4 2025.
Agenus (AGEN) Total Debt (2010 - 2026) Analysis & Trends
Agenus' Total Debt history runs 17 years deep, the most recent figure standing at $30.2 million for Q1 2026.
- On a quarterly basis, Total Debt fell 10.08% year-over-year to $30.2 million in Q1 2026; TTM through Mar 2026 was $30.2 million, a 10.08% decrease from a year earlier, with the FY2025 full-year figure at $44.7 million, up 34.62% from the prior year.
- Total Debt slipped to $30.2 million in Q1 2026 per AGEN's latest filing, from $44.7 million in the prior quarter.
- Across five years, Total Debt topped out at $44.7 million in Q4 2025 and bottomed at $375000.0 in Q3 2022.
- The 5-year median for Total Debt is $13.4 million (2024), against an average of $18.0 million.
- Across the five-year window, Total Debt plunged 97.16% in 2022 and surged 5386.44% in 2025, its largest moves.
- Year by year, Total Debt stood at $13.0 million in 2022, then dropped by 0.76% to $12.9 million in 2023, then surged by 156.86% to $33.2 million in 2024, then soared by 34.62% to $44.7 million in 2025, then slumped by 32.39% to $30.2 million in 2026.
- Per Business Quant, the three latest AGEN Total Debt figures stand at $30.2 million (Q1 2026), $44.7 million (Q4 2025), and $34.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 30.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.19 Mn |
| Dec 31, 2025 | 44.66 Mn |
| Sep 30, 2025 | 34.21 Mn |
| Jun 30, 2025 | 33.87 Mn |
| Mar 31, 2025 | 33.58 Mn |
| Dec 31, 2024 | 33.17 Mn |
| Sep 30, 2024 | 13.40 Mn |
| Jun 30, 2024 | 13.43 Mn |
| Mar 31, 2024 | 612,000.00 |
| Dec 31, 2023 | 12.91 Mn |
| Sep 30, 2023 | 12.96 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 13.65 Mn |
| Dec 31, 2022 | 13.01 Mn |
| Sep 30, 2022 | 375,000.00 |
| Jun 30, 2022 | 655,000.00 |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 13.55 Mn |
| Sep 30, 2021 | 13.18 Mn |
| Jun 30, 2021 | 19.79 Mn |